A new era of antifungal therapy
Open Access
- 29 February 2004
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (2), 73-90
- https://doi.org/10.1016/j.bbmt.2003.09.014
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignanciesCancer, 2003
- Triad of Acute Infusion‐Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological CharacteristicsClinical Infectious Diseases, 2003
- Continuous Infusion of Escalated Doses of Amphotericin B Deoxycholate: An Open‐Label Observational StudyClinical Infectious Diseases, 2003
- In vitro activity of voriconazole, itraconazole, caspofungin, anidulafungin (VER002, LY303366) and amphotericin B against aspergillus sppDiagnostic Microbiology and Infectious Disease, 2003
- Mortality and Costs of Acute Renal Failure Associated with Amphotericin B TherapyClinical Infectious Diseases, 2001
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven AspergillosisClinical Infectious Diseases, 1999
- Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- A Controlled Trial of Fluconazole to Prevent Fungal Infections in Patients Undergoing Bone Marrow TransplantationNew England Journal of Medicine, 1992
- Dopamine and Saralasin Antagonism of Renal Vasoconstriction and Oliguria Caused by Amphotericin B in DogsThe Journal of Infectious Diseases, 1979